Livforsakringsbolaget Skandia’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.29M | Hold |
2,619
| – | – | 0.05% | 150 |
|
|
2025
Q4 | $1.52M | Sell |
2,619
-221
| -8% | -$125K | 0.06% | 147 |
|
|
2025
Q3 | $1.38M | Sell |
2,840
-200
| -7% | -$93.1K | 0.05% | 167 |
|
|
2025
Q2 | $1.23M | Hold |
3,040
| – | – | 0.05% | 175 |
|
|
2025
Q1 | $1.51M | Sell |
3,040
-2,040
| -40% | -$1.1M | 0.09% | 161 |
|
|
2024
Q4 | $2.64M | Hold |
5,080
| – | – | 0.14% | 118 |
|
|
2024
Q3 | $3.14M | Buy |
5,080
+2,732
| +116% | +$1.62M | 0.17% | 110 |
|
|
2024
Q2 | $1.3M | Sell |
2,348
-200
| -8% | -$115K | 0.11% | 142 |
|
|
2024
Q1 | $1.48M | Hold |
2,548
| – | – | 0.13% | 137 |
|
|
2023
Q4 | $1.35M | Buy |
2,548
+211
| +9% | +$102K | 0.13% | 143 |
|
|
2023
Q3 | $1.18M | Sell |
2,337
-100
| -4% | -$53.3K | 0.13% | 150 |
|
|
2023
Q2 | $1.27M | Sell |
2,437
-200
| -8% | -$108K | 0.13% | 151 |
|
|
2023
Q1 | $1.52M | Hold |
2,637
| – | – | 0.16% | 141 |
|
|
2022
Q4 | $1.45M | Hold |
2,637
| – | – | 0.17% | 132 |
|
|
2022
Q3 | $1.34M | Sell |
2,637
-2,580
| -49% | -$1.44M | 0.17% | 130 |
|
|
2022
Q2 | $2.83M | Sell |
5,217
-1,300
| -20% | -$716K | 0.25% | 95 |
|
|
2022
Q1 | $3.85M | Sell |
6,517
-1,860
| -22% | -$1.07M | 0.26% | 93 |
|
|
2021
Q4 | $5.59M | Sell |
8,377
-1,700
| -17% | -$1.06M | 0.36% | 71 |
|
|
2021
Q3 | $5.75M | Sell |
10,077
-1,100
| -10% | -$604K | 0.36% | 72 |
|
|
2021
Q2 | $5.64M | Sell |
11,177
-250
| -2% | -$118K | 0.34% | 75 |
|
|
2021
Q1 | $5.21M | Buy |
11,427
+900
| +9% | +$430K | 0.36% | 71 |
|
|
2020
Q4 | $4.9M | Buy |
10,527
+1,700
| +19% | +$797K | 0.42% | 53 |
|
|
2020
Q3 | $3.9M | Sell |
8,827
-300
| -3% | -$124K | 0.42% | 55 |
|
|
2020
Q2 | $3.31M | Hold |
9,127
| – | – | 0.38% | 64 |
|
|
2020
Q1 | $2.59M | Buy |
9,127
+1,200
| +15% | +$378K | 0.36% | 63 |
|
|
2019
Q4 | $2.58M | Sell |
7,927
-1,500
| -16% | -$455K | 0.31% | 92 |
|
|
2019
Q3 | $2.75M | Buy |
+9,427
| New | +$2.7M | 0.32% | 84 |
|
|
2019
Q2 | – | Sell |
-3,997
| Closed | -$1.09M | – | 638 |
|
|
2019
Q1 | $1.09M | Buy |
3,997
+400
| +11% | +$99.5K | 0.14% | 149 |
|
|
2018
Q4 | $805K | Hold |
3,597
| – | – | 0.12% | 158 |
|
|
2018
Q3 | $878K | Sell |
3,597
-3,500
| -49% | -$805K | 0.1% | 181 |
|
|
2018
Q2 | $1.47M | Buy |
7,097
+1,000
| +16% | +$212K | 0.13% | 161 |
|
|
2018
Q1 | $1.26M | Hold |
6,097
| – | – | 0.12% | 173 |
|
|
2017
Q4 | $1.16M | Sell |
6,097
-1,400
| -19% | -$268K | 0.11% | 180 |
|
|
2017
Q3 | $1.42M | Hold |
7,497
| – | – | 0.13% | 164 |
|
|
2017
Q2 | $1.31M | Hold |
7,497
| – | – | 0.12% | 173 |
|
|
2017
Q1 | $1.15M | Sell |
7,497
-16,000
| -68% | -$2.45M | 0.11% | 191 |
|
|
2016
Q4 | $3.31K | Sell |
23,497
-73,603
| -76% | -$10.9M | 0.17% | 125 |
|
|
2016
Q3 | $2.35M | Buy |
97,100
+62,503
| +181% | +$9.63M | 0.11% | 247 |
|
|
2016
Q2 | $5.11M | Hold |
34,597
| – | – | 0.23% | 90 |
|
|
2016
Q1 | $4.9M | Sell |
34,597
-7,000
| -17% | -$938K | 0.23% | 95 |
|
|
2015
Q4 | $5.9M | Buy |
41,597
+4,000
| +11% | +$534K | 0.28% | 75 |
|
|
2015
Q3 | $4.6M | Hold |
37,597
| – | – | 0.24% | 91 |
|
|
2015
Q2 | $4.88M | Hold |
37,597
| – | – | 0.24% | 93 |
|
|
2015
Q1 | $5.05M | Sell |
37,597
-1,200
| -3% | -$155K | 0.25% | 92 |
|
|
2014
Q4 | $4.86M | Sell |
38,797
-14,000
| -27% | -$1.7M | 0.23% | 97 |
|
|
2014
Q3 | $6.42M | Hold |
52,797
| – | – | 0.24% | 95 |
|
|
2014
Q2 | $6.23M | Hold |
52,797
| – | – | 0.22% | 105 |
|
|
2014
Q1 | $6.35M | Buy |
+52,797
| New | +$6.28M | 0.24% | 97 |
|
Other funds holding TMO
VCM
Livforsakringsbolaget Skandia's TMO Position: Q1 2026 in Review
Livforsakringsbolaget Skandia held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 2,619 shares worth $1.29M. The position accounts for 0.05% of the portfolio, ranked #150.
Livforsakringsbolaget Skandia first reported a position in TMO in Q1 2014 and has held it in 48 quarters since. The position peaked at $6.42M in Q3 2014. 2,596 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Livforsakringsbolaget Skandia held 2,619 shares of Thermo Fisher Scientific worth $1.29M as of Q1 2026.
- Livforsakringsbolaget Skandia left its Thermo Fisher Scientific share count unchanged in Q1 2026.
- Thermo Fisher Scientific made up 0.05% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #150 holding.
- Livforsakringsbolaget Skandia first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 48 quarters since.
- Livforsakringsbolaget Skandia's Thermo Fisher Scientific position peaked at $6.42M in Q3 2014.
- 2,596 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.